JANX
Janux Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$17.83
−1.22%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 75.59x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.17x
- Price / sales
- 45.42x
- Price / cash flow
- -26.43x
Enterprise value
- Enterprise value
- $140.1M
- EV / sales
- 5.84x
- EV / EBITDA
- -1.39x
- EV / EBIT
- -0.98x
- Market cap
- $1.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026